title: [Highlights of the third edition of Chinese guidelines for AIDS diagnosis and treatment(2015)].
abstract: The third edition of Chinese guidelines for AIDS diagnosis and treatment was launched in 2015 by AIDS Professional Group, Society of Infectious Diseases, Chinese Medical Association. New edition emphasizes the importance of timely initiation of anti-retroviral therapy(ART). Like other guidelines, this edition recommends that once the HIV infection is confirmed, the ART should be initiated timely. For patients with HIV and opportunistic infections, once the infections are under control, the ART should be initiated without delay. For AIDS patients complicated with tuberculosis whose CD4 cell counts are less than 200/μL, the ART should start within 2 weeks after the initiation of anti-tuberculosis treatment. In this guideline, the drugs with severe toxicities and poor tolerance are excluded, and new drugs are added such as rilpivrine (RPV) and atazanavir (ATV) because of less toxicity and higher HIV depression effect; and 3TC+TDF+EFV is recommended as the first line regimen. As for children with HIV infection, especially for those less than 5 years, once the infection is confirmed the ART should be initiated immediately. For the prevention of HIV mother to children transmission, new edition recommends that HIV-infected pregnant women start ART early and keep on ART all their lives.
authors.affiliation: Department of Infectious Diseases, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.
authors.forename: Jian-Jun
authors.initials: JJ
authors.lastname: Sun
authors.affiliation: Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai 200040, China.
authors.forename: Hong-Zhou
authors.initials: HZ
authors.lastname: Lu
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000175:diagnosis* / Q000188:drug therapy*; D018791:CD4 Lymphocyte Count; D002648:Child; D002681:China; D005260:Female; D015658:HIV Infections / Q000175:diagnosis* / Q000188:drug therapy*; D006801:Humans; D017410:Practice Guidelines as Topic; D011247:Pregnancy
references.citation: Bull World Health Organ. 2015 Mar 1;93(3):152-60
references.pmid: 25838611
references.citation: N Engl J Med. 2015 Aug 27;373(9):795-807
references.pmid: 26192873
references.citation: AIDS. 2015 Jun 19;29(10):1247-59
references.pmid: 25870982
references.citation: N Engl J Med. 2010 Oct 14;363(16):1510-20
references.pmid: 20942667
references.citation: Clin Infect Dis. 2011 Jun;52(11):1374-83
references.pmid: 21596680
references.citation: N Engl J Med. 2015 Dec 3;373(23):2197-9
references.pmid: 26624554
references.citation: Ann Intern Med. 2014 Jul 1;161(1):1-10
references.pmid: 24979445
references.citation: AIDS. 2008 Sep 12;22(14):1779-87
references.pmid: 18753861
references.citation: J Hepatol. 2015 Jul;63(1):199-236
references.pmid: 25911336
references.citation: Clin Infect Dis. 2015 Jun 1;60 Suppl 3:S196-9
references.pmid: 25972504
references.citation: N Engl J Med. 2015 Dec 3;373(23):2281-7
references.pmid: 26624243
references.citation: AIDS. 2014 Apr 24;28(7):989-97
references.pmid: 24508782
references.citation: AIDS. 2013 Mar 27;27(6):939-950
references.pmid: 23211772
references.citation: N Engl J Med. 2011 Oct 20;365(16):1471-81
references.pmid: 22010913
references.citation: PLoS One. 2014 Apr 11;9(4):e94854
references.pmid: 24728406
references.citation: AIDS. 2002 Jan 25;16(2):299-300
references.pmid: 11807320
references.citation: Cochrane Database Syst Rev. 2014 May 22;(5):CD004772
references.pmid: 24852077
references.citation: Ann Intern Med. 2014 Oct 7;161(7):461-71
references.pmid: 25285539